Recent Key Hires Recent strategic hires of key personnel such as the Chief Medical Officer, Chief Financial Officer, and Chief Business Officer indicate a focus on strengthening leadership and expertise within Athira Pharma, potentially opening up opportunities for collaboration or partnership discussions.
Equity Incentive Plan The launch of the Equity Incentive Plan showcases Athira Pharma's commitment to attracting and retaining top talent in the biopharmaceutical industry. This initiative can be leveraged as a selling point to engage potential hires or for business development discussions.
Publication in Frontiers in Neuroscience The recent publication in Frontiers in Neuroscience highlighting the neuroprotective effects of ATH-1105 positions Athira Pharma as a thought leader in the field of neurodegenerative diseases. This can be utilized to strengthen the company's positioning in the market and attract partnership opportunities.
Stockholder Derivative Action Athira Pharma's announcement of a proposed settlement regarding the Stockholder Derivative Action demonstrates the company's commitment to legal compliance and resolving disputes efficiently. This may offer a level of transparency and stability that is attractive to potential investors or partners.
Financials and Funding With revenue in the range of $10M - $50M and total funding of $104M, Athira Pharma showcases financial stability and growth potential. This information can be utilized to build trust with potential investors, partners, or customers looking to engage with a financially healthy company.
181
$10M$50M
450$50M$100M
167$10M$50M
122$10M$50M
204$10M$50M
112$10M$50M
14$10M
31
1.2K$100M$1B
35Athira Pharma uses 8 technology products and services including Google Analytics, WordPress, NetSuite, and more. Explore Athira Pharma's tech stack below.
| Athira Pharma Email Formats | Percentage |
| First.Last@athira.com | 96% |
| First.Middle@athira.com | 1% |
| F-Last@athira.com | 2% |
| FirstMLast@athira.com | 1% |
Biotechnology ResearchWashington, United States51-200 Employees
At Athira, we aim to restore neuronal health for those suffering from neurological diseases, including Alzheimer’s, Parkinson’s disease dementia, and dementia with Lewy bodies. We are a motivated, impassioned team committed to making a positive impact on human health.
Company Overview
Media & News
Funding & FinancialsAthira Pharma has raised a total of $104M of funding over 8 rounds. Their latest funding round was raised on Jan 20, 2021 in the amount of $104M.
Athira Pharma's revenue is in the range of $10M$50M
Funding & FinancialsAthira Pharma has raised a total of $104M of funding over 8 rounds. Their latest funding round was raised on Jan 20, 2021 in the amount of $104M.
Athira Pharma's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com